Stanley C. Erck

This profile gathers the share dealings of Stanley C. Erck across 2 companies, led by Novavax Inc and Maxcyte, Inc. Over a trading history stretching from 31 January 2016 to 17 June 2026, the count stands at 15 filings.

The open-market record is one-sided, with 2 purchases worth €117k and not one sale. The amount is not disclosed for 1 filing. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 3 share grants and 10 option exercises.

The record was last updated on 22 June 2026 with a share grant in Maxcyte, Inc. The clock since the last published purchase (13 August 2025) now reads 431 days. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.